|
12
|
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
PAR-25-096 · National Institutes of Health · applied research
|
biomedical clinical
ai data science
public health
|
$200,000 |
2024-11-18 |
2026-11-17 |
12 |